These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16243155)

  • 1. The PUVA-turban as an alternative treatment of alopecia associated with chronic graft versus host disease.
    Tekin NS; Tekin IO; Cinar S; Altinyazar HC; Koca R; Esturk E
    J Am Acad Dermatol; 2005 Nov; 53(5):902-3. PubMed ID: 16243155
    [No Abstract]   [Full Text] [Related]  

  • 2. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
    J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PUVA treatment of alopecia totalis.
    Larkö O; Swanbeck G
    Acta Derm Venereol; 1983; 63(6):546-9. PubMed ID: 6198849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease.
    Ghoreschi K; Thomas P; Penovici M; Ullmann J; Sander CA; Ledderose G; Plewig G; Kolb HJ; Röcken M
    Eur J Dermatol; 2008; 18(6):667-70. PubMed ID: 18955201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia Universalis and Chronic Graft-vs-Host Disease Treated With Ruxolitinib.
    Borg MA; Shalabi RA; Childs R; Wells BC
    JAMA Dermatol; 2018 Nov; 154(11):1357-1358. PubMed ID: 30285060
    [No Abstract]   [Full Text] [Related]  

  • 6. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on ocular graft versus host disease.
    Kim SK
    Curr Opin Ophthalmol; 2006 Aug; 17(4):344-8. PubMed ID: 16900025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
    Colombo AA; Rusconi C; Esposito C; Bernasconi P; Caldera D; Lazzarino M; Alessandrino EP
    Transplantation; 2006 Apr; 81(8):1087-92. PubMed ID: 16641591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent alopecia as a manifestation of chronic graft-versus-host disease of the scalp: clinical, dermoscopic and histopathological observations.
    Basilio FMA; Werner B; Mulinari-Brenner F
    Clin Exp Dermatol; 2018 Dec; 43(8):948-949. PubMed ID: 29876958
    [No Abstract]   [Full Text] [Related]  

  • 11. Longstanding alopecia and nail dystrophy are associated with more severe overall chronic graft-versus-host disease in adults.
    Naftulin JS; Penzi LR; Manatis-Lornell A; Yasuda MR; Porter ML; Saavedra A; Senna MM
    Bone Marrow Transplant; 2019 Mar; 54(3):469-472. PubMed ID: 30214010
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous manifestations of chronic graft-versus-host disease.
    Hymes SR; Turner ML; Champlin RE; Couriel DR
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1101-13. PubMed ID: 17085303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation.
    Hirokawa M; Kume M; Wu T; Ishikawa K; Sawada KI
    Bone Marrow Transplant; 2006 Sep; 38(5):387-8. PubMed ID: 16862163
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease.
    Kim JB; Liakopoulou E; Watson JS
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1235-8. PubMed ID: 17509955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience.
    Baum S; Pavlotsky F; Shpiro D; Trau H
    Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Chiang CC; Lin JM; Chen WL; Tsai YY
    Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris.
    Matsushita T; Hasegawa M; Shirasaki F; Fujimoto M; Yamazaki H; Sato S; Takehara K
    Dermatology; 2008; 216(1):64-7. PubMed ID: 18032902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-host disease and phimosis.
    Patel ST; Woodward MN; Williams M; O'Brien M; Chandran H; Parashar K
    J Pediatr Urol; 2008 Apr; 4(2):165-6. PubMed ID: 18631916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
    Couriel D; Carpenter PA; Cutler C; Bolaños-Meade J; Treister NS; Gea-Banacloche J; Shaughnessy P; Hymes S; Kim S; Wayne AS; Chien JW; Neumann J; Mitchell S; Syrjala K; Moravec CK; Abramovitz L; Liebermann J; Berger A; Gerber L; Schubert M; Filipovich AH; Weisdorf D; Schubert MM; Shulman H; Schultz K; Mittelman B; Pavletic S; Vogelsang GB; Martin PJ; Lee SJ; Flowers ME
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):375-96. PubMed ID: 16545722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab.
    Benson DM; Smith MK; Krugh D; Devine SM
    Bone Marrow Transplant; 2008 Mar; 41(6):595-6. PubMed ID: 18037934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.